A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Immunex


Former Immunex Management Team Chosen to Head-Up CTI Subsidiary ...  -  May 14, 2007
PharmaLive.com (press release),Stewart D. Chipman, Ph.D., Vice President of Research at CTI and former Director of Biomolecular Screening at Immunex, who was a co- inventor of the

Spiration, Inc. Names Nancy Hill Vice President, Marketing to ...  -  May 9, 2007
American Digital Networks (press release),Prior to starting her own firm, Nancy held executive marketing positions with Amgen, Berlex Laboratories (now Bayer HealthCare) and Immunex Corporation (now

AstraZeneca's MedImmune Acquisition Should Receive Regulatory Approval  -  Apr 27, 2007
Seeking Alpha,The M & A Researcher submits: The AstraZeneca (AZN) -MedImmune Inc. (MEDI) acquisition deal is the largest biotech deal to surface since the Immunex/Amgen

Hana Bioscienses: Understand the Biotech Game  -  May 15, 2007
Seeking Alpha,Immunex: Forget the insider trading side story,FDA basically told them Enbrel is useful, but not really sure for what. That free fall turned into a huge

Favrille Appoints Richard Ghalie, MD, Chief Medical Officer  -  May 8, 2007
PharmaLive.com (press release),Previously, he was Vice President of Clinical Development and Regulatory Affairs at NeoRx Corp. and spent seven years at Immunex Corp., most recently as

How state GOP can become relevant  -  Apr 26, 2007
Seattle Post Intelligencer,More money is doled out, but "the system" is not meeting the needs of a tech and biotech economy in this land of Microsoft, Immunex, the Hutch Cancer

Targeted Genetics posts Q4 profit, shares soar 50 pct  -  Mar 29, 2007
ReutersH. Stewart Parker managed the formation of Targeted Genetics as a wholly owned subsidiary of Immunex Corporation (Immunex was subsequently acquired by.

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 ...  -  Apr 23, 2007
Genetic Engineering News (press release),...(2) To exclude the ongoing, non-cash amortization of acquired product technology rights, primarily ENBREL, related to the Immunex acquisition.

Pipex Pharmaceuticals Appoints Kay E. Stremler, Ph.D. as Vice ...  -  Apr 18, 2007
Web Services Journal,Prior to joining Boehringer-Ingelheim Pharma, she spent 11 years at Immunex Corporation, where she ultimately held the position of Director,

Gene Logic Board Elects Two New Directors  -  Apr 12, 2007
PharmaLive.com (press release),Prior to that time, he held various positions with Immunex Corporation, including President of Immunex Manufacturing Corporation, Vice President and

Pharmaceutical manufacturing: People on the move  -  Apr 19, 2007
BiopharmaReporter.com,Stremler's previous positions include roles at Pfizer company Esperion therapeurics, Boehringer-Ingelheim and Immunex. CH2M Hill, an engineering,

Oxford Genome Sciences Recruits Senior Industry Professionals  -  Apr 18, 2007
Oxfordshire Bioscience Network (press release),Dr Fitzpatrick has extensive industry experience including seven years at Immunex and Amgen. His pre-clinical expertise includes several therapeutic

Innovative Pulmonary & PEGylation-based Therapeutic Product ...  -  Apr 14, 2007
Medical News Today (press release),Previously, Warner served as the Director of Corporate Communications for Immunex Corporation and Senior Vice President, Marketing, for Widevine

GTx, Inc. Appoints Jeff Hesselberg as Vice President of Regulatory ...  -  Apr 10, 2007
PharmaLive.com (press release),From 1984 to 1996, Mr. Hesselberg worked for Immunex Corporation and the Puget Sound Blood Center. Mr. Hesselberg holds a BS in Molecular Biology from the

First approved prefilled autoinjector for rheumatoid arthritis and ...  -  Apr 4, 2007
CNW Telbec (Communiqués de presse),Immunex Corporation, a wholly owned subsidiary of Amgen, manufactures ENBREL. Additional information about ENBREL, including full Prescribing Information,

Wires Crossed, Girls Gone Legitimate ... and a Contest!  -  Mar 30, 2007
CNBC,...“I can't walk around beating my chest saying I discovered Enbrel," Stine said, referring to the drug made by Immunex Corp., and marketed by Amgen and Wyeth

Tuesday Newspaper Review - Irish Business News and International ...  -  Apr 17, 2007
FinFacts Ireland,And its other big product, the rheumatoid arthritis drug Enbrel, was not homegrown but came as part of the company’s $10 billion acquisition of Immunex in

Invest Northwest highlights biotech  -  Mar 19, 2007
Seattle Post Intelligencer,Invest Northwest will feature presentations by more than 50 public and private companies, with keynotes by biotech leaders such as former Immunex Chief

The Insider: Biotech humor even gives investors a few guffaws  -  Mar 25, 2007
Seattle Post Intelligencer,..."I can't walk around beating my chest saying I discovered Enbrel," Stine said, referring to the drug made by Immunex Corp., and marketed by Amgen and Wyeth

Icos’ arc from rising to fallen star is sadly typical for local ...  -  Feb 26, 2007
Washington CEO,Other firms that rivaled Icos in the number of local employees, such as Immunex, Physio-Control and Spacelabs, were owned by companies from outside the

Invest Northwest 2007 Online Registration Ends Thursday  -  Mar 14, 2007
PR Newswire (press release),The event also includes a gala reception and two keynote speakers, Ed Fritzky, former CEO, Immunex and John Milligan, COO, Gilead Sciences.

SEC fines hedge fund advisor over compliance issue  -  Feb 26, 2007
ReutersH. Stewart Parker managed the formation of Targeted Genetics as a wholly owned subsidiary of Immunex Corporation (Immunex was subsequently acquired by.

Lynnwood lab not part of Bayer layoffs  -  Mar 3, 2007
HeraldNet,The drug, originally developed by Seattle-based Immunex, also is being studied for the treatment of Crohn's disease. Fischer said that facility should not

Spaltudaq Corporation Raises $29 Million  -  Mar 19, 2007
American Venture Magazine (press release),Dr. Gillis was a founder, Chief Scientific Officer, and Interim Chief Executive Officer of Immunex Corp., which was acquired by Amgen Inc. in 2002.

Compassoft and Pharmaceutical Services Corporation Team to Offer ...  -  Mar 19, 2007
TMC Net,Representative customers include ABN AMRO, Allergan, Allied Irish Bank, Alpharma, AstraZeneca, Bayer, CitiGroup, Echostar, Eli Lilly, Immunex,

Invest Northwest 2007 Panels Cover Life Science Company Liquidity ...  -  Mar 7, 2007
PR Newswire (press release),Monday, March 20: Opening Address: * Ed Fritzky, former CEO, Immunex: "A Hot Tub Near, Carefree" Morning Concurrent Panels: * "Life Science Business in

Biotechnology startup rises from Icos ashes  -  Mar 5, 2007
Seattle Post Intelligencer,They are not just going to give that to anybody, so first you have to have the credibility to go in and talk," said Frazier, the former Immunex executive

Vidacare Announces Director of Sales Operations, Bart P. Jones  -  Mar 6, 2007
Business Wire (press release),Mr. Jones has also led sales and marketing initiatives in management positions with Immunex, Inc., Genentech, Inc., Squibb-Novo, Inc., and BHJ Enterprises,

OXiGENE Appoints Chief Business Officer and Head of Business ...  -  Mar 1, 2007
Business Wire (press release),He started his career as a Product Manager with Immunex and held roles in marketing and business development at Elan Pharmaceuticals, Inc. He previously

Cell Therapeutics to create spinoff  -  Feb 12, 2007
Seattle Post Intelligencer,Cell Therapeutics is recruiting management for its new venture and hopes to snap up former Immunex executives because they live in Seattle and have a

CTI spins off new biotech startup  -  Feb 12, 2007
Seattle Post Intelligencer,Those include former employees at Seattle-based Immunex, he said. The cancer research company has hit a number of roadblocks recently, including a plan to

Something's Popping!  -  Feb 13, 2007
Drug Discovery & Development,...of the work was done by Amgen scientists, much of the innovation came through acquisition of intellectual property from companies such as Immunex.

Omeros triples its funding goal  -  Feb 12, 2007
Seattle Post Intelligencer,Demopulos said he created the company in 1994 with the help of the "Seattle biotech mafia" -- the same group of investors who funded Immunex and other

Cell Therapeutics Spin-off to Use Genetic Technology to Develop ...  -  Feb 13, 2007
GenomicsProteomics.com (press release),...“We have begun recruiting a scientific and management team, including former members of the Immunex-Enbrel management team, that will have the requisite

Promedior Adds to Management Team  -  Feb 12, 2007
Business Wire (press release),Dr. Lupher has held various R&D positions at biopharmaceutical companies such as ICOS Corporation and Immunex. Dr. Lupher holds a Ph.D. in Immunology from

Court rules for Amgen in Enbrel-related patent suit  -  Jan 29, 2007
MarketWatchThe patent dispute, on the face of it, covers a protein used to treat rheumatoid arthritis that was originally licensed to Immunex Corp. before it was

Invest Northwest 2007 Keynote Speakers to be Edward Fritzky and ...  -  Dec 22, 2006
Yahoo! News (press release)From January 1994 to July 2002, Mr. Fritzky served as chief executive officer, president and chairman of the board of directors of Immunex Corporation.

Lessons from Icos  -  Dec 20, 2006
Seattle Times,Immunex becomes Amgen, and shrinks but stays. Corixa is bought and is gone. Corus is bought and expanded. Maybe Icos goes poof.

Something's Popping!  -  Jan 15, 2007
Drug Discovery & Development,...of the work was done by Amgen scientists, much of the innovation came through acquisition of intellectual property from companies such as Immunex.

2006 the year in the News  -  Jan 6, 2007
Magnolia News,Biotech giant Amgen, formerly Immunex, announced plans for a major expansion of its campus north of the grain terminal and near the shores of Elliott Bay.

Fifty-Seven Life Science Companies Selected to Present at Invest ...  -  Jan 4, 2007
Drug Newswire (press release),...president and CEO of Immunex, and John Milligan, Executive VP and CFO, Gilead Sciences, plus industry panel discussions and a networking reception.

Invest Northwest 2007 Keynote Speakers to be Edward Fritzky and ...  -  Dec 22, 2006
Yahoo! News (press release)From January 1994 to July 2002, Mr. Fritzky served as chief executive officer, president and chairman of the board of directors of Immunex Corporation. ...

Keep part of ICOS here, Inslee urges  -  Dec 14, 2006
HeraldNet,...sciences companies. After Amgen's buyout of Seattle-based Immunex, ICOS became the largest biotech firm based in Washington. The ...

Lessons from Icos  -  Dec 20, 2006
Seattle Times,That is the atmosphere of biotech: always in ferment. Immunex becomes Amgen, and shrinks but stays. Corixa is bought and is gone. Corus is bought and expanded. ...

Celgene Appoints Thomas O. Daniel, MD as President of Global ...  -  Dec 7, 2006
Yahoo! News (press release)Prior to Amgen's acquisition of Immunex, Dr. Daniel was Senior Vice President of Discovery Research at Immunex, where he consolidated and built programs in ...

Celgene names research chief  -  Dec 7, 2006
BusinessWeekAmgen Inc. Before Amgen's acquisition of Immunex, Daniel was senior vice president of discovery research for that company. He will ...

Icos sale may cost 700 jobs  -  Dec 11, 2006
Seattle Post IntelligencerA complete shutdown of Icos is a far different outcome from what occurred when Amgen bought Immunex, another blockbuster deal in Seattle's biotechnology ...

Opponents of Icos buyout gather steam: Major shareholder Bill ...  -  Dec 18, 2006
King County Journal,Inslee also pointed out how the decision by Amgen, the out-of-state biotech giant that acquired Seattle-based Immunex in 2002, to keep the company's local ...

ICOS closure 'a huge blow'  -  Dec 13, 2006
HeraldNet,...center. Since Seattle's Immunex was bought out in 2002 by Amgen, ICOS had been the industry's largest company based in Washington. ...

Garden State Business Briefs  -  Dec 7, 2006
Newark Star Ledger,...giant Amgen. Before Am gen's acquisition of Immunex, Daniel was senior vice president of discovery research for that company. He ...


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional